Drugs.com is the most popular, comprehensive and up-to-date source of drug information online. Providing free, peer-reviewed, accurate and independent data on more than 24,000 prescription drugs, over-the-counter medicines & natural products.

FDA Approves Andembry (garadacimab-gxii) for Prophylaxis to Prevent Attacks of Hereditary Angioedema

Global biotechnology leader CSL today announced the U.S. Food and Drug Administration (FDA) approved Andembry (garadacimab-gxii), the only treatment targeting...

yesterday New Drug Approvals

FDA Approves Keytruda (pembrolizumab) for PD-L1+ Resectable Locally Advanced Head & Neck Squamous Cell Carcinoma as Neoadjuvant Treatment, Continued as Adjuvant Treatment Combined With Radiotherapy

(BUSINESS WIRE) June 13, 2025 -- Merck (NYSE: MRK), known as MSD outside of the United States and Canada, today announced that the U.S. Food and Drug Administration...

3 days ago New Drug Approvals

Recently Added

Recently added consumer and prescribing information: Ibtrozi, Miudella, Opdivo Qvantig, Alyftrek, Crenessity, Ensacove, Steqeyma, Yesintek, Revuforj, Danziten

For Consumers

For Professionals

For Researchers

Pharmaceutical Company Directory

Latest FDA New Drug Approvals

Andembry Andembry (garadacimab-gxii) is an activated Factor XII (FXIIa) inhibitor (monoclonal antibody) indicated for prophylaxis to prevent attacks...
Zusduri Zusduri (mitomycin) is a sustained release, hydrogel-based formulation of mitomycin for intravesical treatment of low-grade...
Ibtrozi Ibtrozi (taletrectinib) is a kinase inhibitor indicated for the treatment of adult patients with locally advanced or metastatic...

More FDA approvals

Drug Information

Tools

News & Alerts

Professionals

Top 100 Drugs

Recommended Content

Find Drugs & Conditions

Church & Dwight Issues Voluntary Nationwide Recall of Zicam Cold Remedy Nasal Swabs, Zicam Nasal AllClear Swabs, and Orajel Baby Teething Swabs Due to Microbial Contamination

FDA Approves Andembry (garadacimab-gxii) for Prophylaxis to Prevent Attacks of Hereditary Angioedema

Texas Invests $50M in Psychedelic Drug Research into Ibogaine to Treat Addiction

FDA Approves Andembry (garadacimab-gxii) for Prophylaxis to Prevent Attacks of Hereditary Angioedema

FDA Approves Keytruda (pembrolizumab) for PD-L1+ Resectable Locally Advanced Head & Neck Squamous Cell Carcinoma as Neoadjuvant Treatment, Continued as Adjuvant Treatment Combined With Radiotherapy

Moderna Receives U.S. FDA Approval for RSV Vaccine, mRESVIA, in Adults Aged 18–59 at Increased Risk for RSV Disease

FDA Approves Zusduri (mitomycin) for Recurrent Low-Grade Intermediate-Risk Non-Muscle Invasive Bladder Cancer

FDA Approves Ibtrozi (taletrectinib) for Advanced ROS1-Positive Non-Small Cell Lung Cancer

FDA Approves Xifyrm (meloxicam) Injection for the Management of Moderate-to-Severe Pain in Adults

Psychedelics Can Help Cancer Patients Battling Depression

Dementia Caregivers Themselves At Higher Risk For Brain Aging

Blood Pressure Diet Helps Type 2 Diabetics

Electroshock Therapy Appears To Reduce Suicide Risk Among People With Depression

Psilocybin Plus Psychotherapy Offers Lasting Benefit in Cancer, Depression

Parent-Reported Firearm Storage Poor Estimator of Teen Perceived Access

Incidence Rates of Appendiceal Adenocarcinoma Increasing

CT Colonography Cost-Effective, Clinically Effective for CRC Screening

Building Strength May Take Less Exercise Than You Think

Johnson & Johnson’s Dual-Targeting CAR T-Cell Therapy Shows Encouraging First Results in Large B-Cell Lymphoma

Alligator Bioscience Receives FDA Endorsement of Mitazalimab Phase 3 Dose for Pancreatic Cancer

Recently Added

For Consumers

For Professionals

For Researchers

Latest FDA New Drug Approvals

Drug Information

Tools

News & Alerts

Professionals

Top 100 Drugs